Vnitr Lek 2021, 67(5):e28-e33 | DOI: 10.36290/vnl.2021.085

D-lactic acidosis - a rare complication of short bowel syndrome

Vladimír Podušel1, Simona Morgošová1, Pavol Majdák1, Jurina Sadloňová2
1 Interné oddelenie, NsP Prievidza so sídlom v Bojniciach
2 I. interná klinika Jesseniovej lekárskej fakulty UK a Univerzitnej nemocnice v Martine

D-lactic acidosis represents a rare form of metabolic acidosis that occurs most commonly in patients with short bowel syndrome. This is a serious, sometimes life-threatening complication. The cause is the accumulation of D-lactate in the body, which is formed in excessive amounts by fermentation of unabsorbed carbohydrates by the intestinal microbiota. The nervous system is predominantly affected, which also results in clinical manifestations. The clinical picture is dominated by a wide range of non-specific neurological symptoms. The disease can sometimes manifest as somnolence to coma. From the aspect of laboratory diagnostics, the disease is characterized by severe metabolic acidosis with an increased anion gap. In this case report, we present a unique case of a 54-year-old woman with Crohn's disease and short bowel syndrome who in a short time was repeatedly hospitalized for recurrence of severe metabolic acidosis with severe impaired consciousness. Based on the evaluation of anamnestic data, clinical picture and laboratory tests, the patient was diagnosed with D-lactic acidosis. In the discussion we discuss the individual steps that led to this diagnosis and compare our experience with data in the world literature.

Keywords: D-lactic acidosis, encephalopathy, short bowel syndrome.

Published: August 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Podušel V, Morgošová S, Majdák P, Sadloňová J. D-lactic acidosis - a rare complication of short bowel syndrome. Vnitr Lek. 2021;67(5):e28-33. doi: 10.36290/vnl.2021.085.
Download citation

References

  1. Pironi L, Corcos O, Forbes A et al. Intestinal failure in adults: Recommendations from the ESPEN expert groups. Clin Nutr. 2018; 37: 1798-1809. Go to original source... Go to PubMed...
  2. O'Keefe SJ, Buchman AL, Fishbein TM et al. Short Bowel Syndrome and Intestinal Failure: Consensus Definitions and Overview. Clin Gastroenterol Hepatol. 2006; 4: 6-10. Go to original source... Go to PubMed...
  3. Oh MS, Phelps KR, Traube M, Barbosa-Saldivar JL et al. D-Lactic acidosis in a man with the short-bowel syndrome. N Engl J Med. 1979; 301: 249-252. Go to original source... Go to PubMed...
  4. Mason PD. Metabolic acidosis due to D-lactate. Br Med J. 1986; 292: 1105-1106. Go to original source... Go to PubMed...
  5. Wright MR, Jamali F. Methods for the analysis of enantiomers of racemic drugs application to pharmacological and pharmacokinetic studies. J Pharmacol Toxicol Methods. 1993; 29: 1-9. Go to original source... Go to PubMed...
  6. Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998; 77: 73-82. Go to original source... Go to PubMed...
  7. Petersen C. D-lactic acidosis. Nutr Clin Pract. 2005; 20: 634-645. Go to original source... Go to PubMed...
  8. Spillane K, Nagendran K, Prior PF et al. Serial electroencephalograms in a patient with D-lactic acidosis. Electroencephalogr Clin Neurophysiol. 1994; 91: 403-405. Go to original source... Go to PubMed...
  9. Kowlgi NG, Chhabra L. D-Lactic Acidosis: An Uderrecognized Complication of Short Bowel Syndrome. Gastroenterol Res Pract. 2015; 2015: 476215. doi: 10.1155/2015/476215. Go to original source... Go to PubMed...
  10. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med. 1995; 122: 839-842. Go to original source... Go to PubMed...
  11. Flourie B, Messing B, Bismuth E et al. D-lactic acidosis and encephalopathy in short-bowel syndrome occurring during antibiotic treatment. Gastroenterol Clin Biol. 1990; 14: 596-598. Go to PubMed...
  12. Yilmaz B, Schibli S, Macpherson AJ et al. D-lactic Acidosis: Successful Suppression of D-lactate-Producing Lactobacillus by Probiotics. Pediatrics. 2018; 142(3): e20180337. doi: 10.1542/peds.2018-0337. Go to original source... Go to PubMed...
  13. Day AS, Abbott GD. D-lactic acidosis in short bowel syndrome. N Z Med J. 1999; 112: 277-278. Go to PubMed...
  14. Hudson M, Pocknee R, Mowat NAG. D-lactic acidosis in short bowel syndrome-an examination of possible mechanisms. Q J Med. 1990; 74: 157-163.
  15. Hyšpler R et al. Spektrofotometrická metóda stanovení D-laktátu v krevní plazmě a moči. Klin. Biochem. Metab. 2015; 23: 193-197.
  16. Weemaes M, Hiele M, Vermeersch P. High anion gap metabolic acidosis caused by D-lactate: mind the time of blood collection. Biochem Med (Zagreb). 2020; 30: 1-5. Go to original source... Go to PubMed...
  17. Mayne AJ, Handy DJ, Preece MA et al. Dietary management of D-lactic acidosis in short bowel syndrome. Arch Dis Child. 1990; 65: 229-231. Go to original source... Go to PubMed...
  18. Joyce E, Glasner P, Ranganathan S et al. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol. 2017; 32(4): 577-587. Go to original source... Go to PubMed...
  19. Pham AQ, Xu LH, Moe OW. Drug-Induced Metabolic Acidosis. F1000Res. 2015; 4: F1000 Faculty Rev-1460. Published 2015 Dec 16. doi:10.12688/f1000research.7006.1 Go to original source... Go to PubMed...
  20. Takahashi K, Terashima H, Kohno K et al. A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome. Int Surg. 2013; 98: 110-113. Go to original source... Go to PubMed...
  21. Fabian E, Kramer L, Siebert F et al. D-lactic acidosis - case report and review of the literature. Z Gastroenterol. 2017; 55: 75-82. Go to original source... Go to PubMed...
  22. Godey F, Bouasria A, Ropert M et al. Don't forget to test for D-lactic acid in short bowel syndrome. Am J Gastroenterol. 2000; 95: 3675-3677. Go to original source... Go to PubMed...
  23. Bongaerts G, Tolboom J, Naber T et al. D-lactic acidemia and aciduria in pediatric and adult patients with short-bowel syndrome. Clin Chem. 1995; 41: 107-110. Go to original source...
  24. Narula RK, El Shafei A, Ramaiah D et al. D-lactic acidosis 23 years after jejuno-ileal bypass (case report). Am J Kidney Dis. 2000; 36: 1-4. Go to original source... Go to PubMed...
  25. Dahlquist NR, Perrault J, Callaway CW et al. D-lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc. 1984; 59: 141-145. Go to original source... Go to PubMed...
  26. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med. 1995; 122: 839-842. Go to original source... Go to PubMed...
  27. Flourie B, Messing B, Bismuth E et al. D-lactic acidosis and encephalopathy in short-bowel syndrome occurring during antibiotic treatment. Gastroenterol Clin Biol. 1990; 14: 596-598. Go to PubMed...
  28. White L. D-lactic acidosis: more prevalent than we think? Practical Gastroenterology 2015; 39: 26-45.
  29. Uchida H, Yamamoto H, Kisaki Y et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. 2004; 39: 634-636. Go to original source... Go to PubMed...
  30. Mann NS, Russman HB, Mann SK et al. Lactulose and severe lactic acidosis. Ann Intern Med 1985; 103: 637. Go to original source... Go to PubMed...
  31. Jorens PG, Demey HE, Schepens PJ et al. Unusual D-lactic acid acidosis from propylene glycol metabolism in overdose. J Toxicol Clin Toxicol. 2004; 42: 163-169. Go to original source... Go to PubMed...
  32. Bongaerts G, Bakkeren J, Severijnen R et al. Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr. 2000; 30(3): 288-293. Go to original source... Go to PubMed...
  33. Hove H, Mortensen PB. Colonic lactate metabolism and D-lactic acidosis. Dig Dis Sci. 1995; 40: 320-330. Go to original source... Go to PubMed...
  34. Ponziani FR, Scaldaferri F, Petito V et al. The role of antibiotics in gut microbiota modulation: the eubiotic effects of rifaximin. Dig Dis. 2016; 34(3): 269-278. Go to original source... Go to PubMed...
  35. Scully TB, Kraft SC, Carr WC et al. D-lactate-associated encephalopathy after massive small-bowel resection. J Clin Gastroenterol. 1989; 11: 448-451. Go to original source... Go to PubMed...
  36. Satoh T, Narisawa K, Konno T et al. D-lactic acidosis in two patients with short bowel syndrome: bacteriological analyses of the fecal flora. Eur J Pediatr 1982; 138: 324-326. Go to original source... Go to PubMed...
  37. Ondriová I, Fertaľová T, Magurová D. Klinické využitie probiotík v prevencii a liečbe porúch tráviaceho traktu. Klin Farmakol Farm. 2015; 29(3): 116-118.
  38. Gombošová L. Mikrobiota v etiopatogenéze a liečbe symptomatickej divertikulovej choroby hrubého čreva. Gastroent Hepatol. 2019; 73: 418-422. Go to original source...
  39. Cherbut C, Aubé AC, Blottière HM et al. Effects of short-chain fatty acids on gastrointestinal motility. Scand J Gastroenterol Suppl 1997; 222: 58-61. Go to original source... Go to PubMed...
  40. Pape UF, Iyer KR, Jeppesen PB et al. Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials. Therap Adv Gastroenterol. 2020; 13: 1-18. Go to original source... Go to PubMed...
  41. Křížová J, Trachta P, Kotrlíková E et al. Syndrom krátkeho střeva a možnosti jeho léčby. Interná med. 2017; 17(10): 405-408.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.